logo
episode-header-image
Jan 26
27m 8s

IgA Nephropathy in Adults

JAMA NETWORK
About this episode
tail spinning
Up next
Jan 21
Restless Legs Syndrome
Restless legs syndrome is a sleep-related neurologic disorder that causes an overwhelming urge to move the limbs, which can cause substantial sleep disturbance. Author John W. Winkelman, MD, PhD, of Harvard Medical School joins JAMA Deputy Editor Kristin Walter, MD, MS, to discus ... Show More
23m 26s
Jan 12
A Conversation About the FDA's Regulation of Mifepristone
Mifepristone used with misoprostol is the most common abortion regimen in the US. It is also a focal point of reproductive health policy and politics, with controversy over its legal status and regulation by the US Food and Drug Administration (FDA). Author G. Caleb Alexander, MD ... Show More
20m 47s
Jan 7
Gastric Cancer Worldwide
Incidence rates of gastric cancer in younger individuals are on the rise and gastric cancer is the fifth-leading cause of cancer-related deaths worldwide. JAMA Review author Haeseong Park, MD, MPH, from the Dana Farber Cancer Institute, discusses this and more with JAMA Senior Ed ... Show More
13m 17s
Recommended Episodes
Aug 2023
Obesity Rx: How to Use New Medications in Clinic
Drs Robert Kushner and obesity pharmacotherapy expert Ania Jastreboff discuss how to use the new obesity medications effectively in clinic. Tune in to hear expert recommendations on patient communication, side effects, and more. Relevant disclosures can be found with the episode ... Show More
21m 49s
Apr 2023
Obesity as a Disease: Changing the Paradigm
How can you change the paradigm on obesity as a disease? In this episode, Drs Robert Kushner and Donna Ryan dig into the science, speak about bias within the healthcare system, and advocate for better patient care. Relevant disclosures can be found with the episode show notes on ... Show More
19m 24s
Sep 2019
National Obesity Care Week with Dr. Chandra
Join Dr. Chandra as she discusses the importance of understanding the risks of obesity and how we can address the disease during National Obesity Care Week. 
3m 34s
Feb 2025
America’s Obesity Crisis: Is Ozempic a Cure or a Cover-Up? | Calley Means and Tyna Moore
The rise in obesity and chronic disease over the years is alarming. Rather than genetics, it can be attributed to environmental and dietary changes, emphasizing the role of food quality over quantity. And while GLP-1 agonists like Ozempic may show some promise in addressing metab ... Show More
1h 2m
Jul 2025
122 | How to Support Patients on Obesity Medications: A Short Course on Side Effects, Satiety & Supplements
<p><a href='https://www.examroomnutrition.com/course'>Join The Obesity Medicine Nutrition Course</a>! Enter code POD15 at checkout for 15% off!</p><p>Anti-obesity medications are everywhere—but they also come with new challenges. From rapid weight loss and side effects to TikTok- ... Show More
29m 21s
Oct 2024
#320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape
tail spinning
20m 36s
Oct 2024
#537: Appetite Regulation, Metabolic Compensation and More – Stephan Guyenet, PhD
<p>This is an "ask me anything" (AMA) episode with Dr. Stephan Guyenet, an expert in obesity neuroscience and eating behavior. <strong>This episode was originally published on <a href="https://sigmanutrition.com/premium/" target= "_blank" rel="noreferrer noopener follow" data-wpe ... Show More
1h 4m
Jul 2024
Tara Swart (Neuroscientist): The Science Behind Stress, Body Fat & Manifestation (E273)
<p>In this episode, respected neuroscientist and author Dr. Tara Swart joins Jake to uncover fascinating perspectives about the complex interplay between our brains and bodies.</p><br><p>Tara sheds light on how our constant smartphone use impacts us both mentally and physically, ... Show More
56m 42s
Dec 2024
How Ozempic Transformed the Way We Look at Obesity
Ozempic, Wegovy, and Mounjaro, are being called “miracle drugs” with users boasting about their fast results. Dr. Sanjay Gupta takes a deep dive into how they disrupted the entire weight loss industry and changed the conversation about obesity.  Learn more about your ad choices. ... Show More
23m 47s
May 2024
#323: The Hidden Risks of Weight-Loss Drugs: Behind the GLP-1 Hype with Ragen Chastain
Writer, speaker, and weight-inclusive health/fitness professional Ragen Chastain joins us to discuss the potential side effects and other downsides of using GLP-1 drugs (like Ozempic and its ilk) for weight loss, the massive influence the manufacturers of these drugs are having o ... Show More
38m 48s
Listen to millions of songs and podcasts on Anghami